Pennsylvania HB2545: An Act providing for insurance coverage for vaginal estrogen for the treatment of menopausal symptoms and urinary tract infections.

What the bill says

From the introduced text, May 27, 2026:

PRINTER'S NO. 3452 THE GENERAL ASSEMBLY OF PENNSYLVANIA HOUSE BILL No. Session of INTRODUCED BY SHUSTERMAN, D. WILLIAMS AND PARKER, MAY 27, 2026 REFERRED TO COMMITTEE ON INSURANCE, MAY 27, 2026 Providing for insurance coverage for vaginal estrogen for the treatment of menopausal symptoms and urinary tract infections. The General Assembly of the Commonwealth of Pennsylvania hereby enacts as follows: Section 1. Short title. This act shall be known and may be cited as the Insurance Coverage for Vaginal Estrogen Act. Section 2. Definitions. The following words and phrases when used in this act shall have the meanings given to them in this section unless the context clearly indicates otherwise: "Cost sharing." The following: (1) The share of the health care costs covered by a health insurance policy that an enrollee or covered person pays out of pocket. (2) The term includes a deductible, coinsurance, copayment or similar charge. (3) The term does not include a premium, a balance billed amount from an out-of-network provider or the cost of a noncovered service. "Department." The Insurance Department of the Commonwealth. "Health insurance policy." A policy, subscriber contract, certificate or plan issued by an insurer that provides medical or health care coverage. The term does not include any of the following: (1) An accident only policy. (2) A credit only policy. (3) …

Read the full official text

Sponsors

• Melissa Shusterman (D, 157) · primary sponsor
• Dan Williams (D, 74)
• Darisha Parker (D, 198)
• Mary Isaacson (D, 175)
• Heather Boyd (D, 163)
• Tiburcio, Ana (D, 22)
• Joseph Hohenstein (D, 177)
• Jacklyn Rusnock (D, 126)
• David Madsen (D, 104)
• Keith Harris (D, 195)

Latest actions

1. October 27, 2026: Referred to BANKING AND INSURANCE, Oct. 27, 2026
2. October 27, 2026: In the Senate
3. October 21, 2026: (Remarks see House Journal Page ), Oct. 21, 2026
4. October 21, 2026: Third consideration and final passage, Oct. 21, 2026 (153-50)
5. October 21, 2026: Re-reported as committed, Oct. 21, 2026
6. October 20, 2026: Re-committed to APPROPRIATIONS, Oct. 20, 2026
7. October 20, 2026: Second consideration, Oct. 20, 2026
8. October 19, 2026: Removed from table, Oct. 19, 2026
9. September 29, 2026: Laid on the table, Sept. 29, 2026
10. September 29, 2026: First consideration, Sept. 29, 2026

Votes

• House Floor: HB2545, RC 1577 (October 21, 2026): 153 yea, 50 nay, passed
• House Appropriations: Re-report Bill As Committed (October 21, 2026): 37 yea, 0 nay, passed
• House Aging & Older Adult Services: Report Bill As Amended (September 29, 2026): 23 yea, 3 nay, passed
• House Aging & Older Adult Services: Adopt Amendment (September 29, 2026): 24 yea, 2 nay, passed
• House Insurance: Re-refer Bill To Another Committee (June 24, 2026): 26 yea, 0 nay, passed

Common questions

What is HB2545?

HB2545 is a bill in the Pennsylvania Legislature (2025-2026 Regular Session): An Act providing for insurance coverage for vaginal estrogen for the treatment of menopausal symptoms and urinary tract infections.

What is the status of HB2545?

Passed one chamber as of October 27, 2026. Latest action: Referred to BANKING AND INSURANCE, Oct. 27, 2026 (October 27, 2026).

Who sponsored HB2545?

Melissa Shusterman (D, 157), with 9 co-sponsors.

Where is the official record for HB2545?

On the Pennsylvania Legislature website: https://www.palegis.us/legislation/bills/2025/hb2545